Related Experiment Video
Updated: Jun 17, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Tuberculosis preventive treatment in newborns
Tony TannousTahan1, Andrea Maciel de Oliveira Rossoni2, Giuliana Lugarini3
1Universidade Federal do Paraná, Curitiba, PR, Brazil.
Insights
Tuberculosis preventive treatment (TPT) in newborns showed high adherence and safety, with no cases of disease progression or death observed in this Brazilian study. This highlights TPT
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Neonatal tuberculosis remains a significant global health concern.
- Preventive treatment is crucial for infants exposed to Mycobacterium tuberculosis.
Purpose of the Study:
- To assess the safety and effectiveness of tuberculosis preventive treatment (TPT) in newborns.
- To describe TPT cases in Paraná, Brazil, from 2009-2016.
Main Methods:
- Observational, descriptive case series using secondary data from 2009-2018.
- Analysis of TPT information systems, TB registries, and mortality data.
- Evaluation of 24 newborns receiving TPT, with median treatment onset at 23 days.
Main Results:
- High treatment completion rate (83.3%) among 24 newborns.
- Most exposures occurred at home (95.8%), with mothers as the source in 33.3%.
- Two infants experienced mild gastrointestinal adverse events; no TB progression or deaths were recorded during follow-up.
Conclusions:
- TPT in newborns demonstrated high adherence and safety.
- The study indicates 100% protection against tuberculosis infection progression in this cohort.
- Findings support TPT as an effective strategy for preventing childhood TB.
Objective:
To describe the reported cases of newborns subjected to tuberculosis preventive treatment (TPT) in the state of Paraná, Brazil, and to evaluate the safety and effectiveness in preventing the progression of TB disease in this population.
Method:
Observational, descriptive case series, with secondary data. The characteristics of the participants were analyzed from the information systems of preventive treatment of TB (of Paraná), between 2009 and 2016. To evaluate which children had developed tuberculosis later or died, we used the data from the information systems of TB (in Brazil), and mortality (in Paraná), covering the years 2009 to 2018.
Results:
A total of 24 children underwent TPT with the age at treatment onset ranging from 0 to 87 days (median: 23 days). In 95.8 %, the exposure occurred at home, and in 33.3 % of cases, the mother was the source of the infection. A total of 20.8 % of the children tested positive for tuberculosis test at 3 months of age, 83.3 % completed treatment, and 2 experienced adverse events (gastrointestinal issues). No children developed TB or died during the minimum of a 2-year evaluation period through the official databases.
Conclusions:
In this case series, the adherence to the plan was high, with few adverse events and 100 % protection against infection.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: